Michael Geffner, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 12,338 shares at $12.99 ($160K) on 2025-04-09, disclosed to the SEC on 2025-04-11.
Open-market sale of $160k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.99 | 6,169 | $80K | 50.0% |
| 2 | $12.99 | 6,169 | $80K | 50.0% |
| Total | $12.99 avg | 12,338 | $160K | 100% |
| Filing → |
| IMVT | SELL | 2025-07-25 | $43K | — | Filing → |
| IMVT | SELL | 2025-07-11 | $20K | — | Filing → |
| IMVT | SELL | 2025-04-25 | $35K | — | Filing → |